Two-year outcomes after mitraclip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.

Back

ESC Premium Access

Two-year outcomes after mitraclip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.

Session: Devices and multidisciplinary interventions in heart failure

Topic: CHF - Non pharmacological treatment

Speaker: Doctor A. Scotti (Bronx, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Scotti

Montefiore Medical Center, Bronx (United States of America)

0 follower

9 more presentations in this session

Observed versus predicted mortality after mitraclip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation

Speaker: Doctor A. Scotti (Bronx, US)

Distinct hemodynamic changes after interventional mitral valve edge to edge repair in different phenotypes of heart failure

Speaker: Doctor B. Schrage (Hamburg, DE)

Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study

Speaker: Professor J. Davy (Montpellier, FR)

Acute modifications of left ventricular torsional mechanics induced by cardiac resynchronization therapy affect short-term reverse remodelling

Speaker: Professor P. Marino (Novara, IT)

The role of myocardial fibrosis in the recovery of left ventricular ejection fraction after TAVI

Speaker: Doctor A. Sedaghat (Bonn, DE)

Access the full session

Devices and multidisciplinary interventions in heart failure

Speakers: Doctor A. Scotti, Doctor A. Scotti, Doctor B. Schrage, Professor J. Davy, Professor P. Marino...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources